Close
FINDING CURES TOGETHER<sup>SM</sup>

Cancer Research Catalyst: New Drug Approval Will Benefit Leukemia Patients

Earlier this month we witnessed another leap forward for immunotherapy when the FDA approved blinatumomab (Blincyto) for the treatment of certain patients with acute lymphoblastic leukemia (ALL).

AACR in the News

Lee W. Wattenberg, MD, memorialized in The New York Times

​A past president and Fellow of the AACR Academy, Dr. Wattenberg was known as the father of chemoprevention.